To the content
2 . 2022

Oncohematological diseases in the Russian Federation and in developed countries: mortality, incidence, resources and organization of medical assistance in consideration of the COVID-19 pandemic

Abstract

The purpose of the scientific work is to study the mortality and incidence of oncohematological diseases in the Russian Federation (RF) in comparison with developed countries (Great Britain, Germany, Spain, Italy, Canada, Poland, USA, Turkey, Finland, France, South Korea, Japan), as well as resources and volumes of medical care for patients of this profile. It was revealed that from 2012 to 2020 in the Russian Federation, mortality from all malignant neoplasms of lymphatic and hematopoietic tissue increased by 16%. In 2020, in the Russian Federation, compared with Germany, the primary incidence of non-Hodgkin’s lymphomas was 47% lower, leukemia – 21% lower, multiple myeloma – 36% lower, Hodgkin’s lymphoma – 9% lower. In 2020, in the Russian Federation, compared to Germany, the mortality rate from all of the above cancers was also lower, with the exception of Hodgkin’s lymphoma, the mortality rate from which was 3 times higher than in Germany. In the Russian Federation, compared with Germany, the ratio of mortality to primary morbidity in non-Hodgkin’s lymphomas was 34% higher, leukemia – 25% higher, multiple myeloma – at the same level, Hodgkin’s lymphoma – 2 times higher. In the Russian Federation, the prevalence of oncohematological diseases is growing annually by 6.8 thousand people on average, against this background, from 2019 to 2020, the volume of assistance is reduced by 0.5%.The results of a comparative study indicate that in the Russian Federation there is an insufficient detection of oncohematological diseases, their ineffective treatment, as evidenced by the high ratio of mortality to primary morbidity, as well as insufficient assistance, which does not reflect the growth rate in the number of patients with this pathology. All this can lead to an increase in mortality from cancer of the lymphatic and hematopoietic tissue.

Keywords:malignant neoplasms; mortality from malignant neoplasms of lymphatic and hematopoietic tissue; primary incidence of malignant neoplasms of lymphatic and hematopoietic tissue; annual increase in the number of patients with malignant neoplasms of the lymphatic and hematopoietic tissue; volumes of medical care for malignant neoplasms of the lymphatic and hematopoietic tissue

Funding. The study had no sponsor support.

Conflict of interest. The authors declare no conflict of interest.

Contribution. Scientific management of the study, interpretation of the results – Ulumbekova G.E.; collection and generalization of statistical materials – Petrachkov I.V.

For citation: Ulumbekova G.E., Petrachkov I.V. Oncohematological diseases in the Russian Federation and in developed countries: mortality, incidence, resources and organization of medical assistance in consideration of the Covid-19 pandemic. ORGZDRAV: novosti, mneniya, obuchenie. Vestnik VSHOUZ [HEALTHCARE MANAGEMENT: News, Views, Education. Bulletin of VSHOUZ]. 2022; 8 (2): 22–47. DOI: https://doi.org/10.33029/2411-8621-2022-8-2-22-47 (in Russian)

References

1. Ulumbekova G.E., Ginoyan A.B., Petrachkov I.V. Factors influencing mortality from neoplasms and diseases of the circulatory system in the Russian Federation from 2019 to 2020. ORGZDRAV: novosti, mneniya, obuchenie. Vestnik VShOUZ [ORGZDRAV: News, Opinions, Training. Bulletin of VShOUZ]. 2021; 3 (25): 4–23. (in Russian)

2. The state of oncological care for the population of Russia in 2020. In: A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU «FMITs radiologii» Minzdrava Rossii, 2021: 239 p. (in Russian)

CHIEF EDITOR
CHIEF EDITOR
Guzel E. Ulumbekova
MD, MBA from Harvard University (Boston, USA), Head of the Graduate School of Healthcare Organization and Management (VSHOUZ)
Вскрытие
Medicine today

Уважаемые коллеги! Представляем оргкомитет 17-го Национального конгресса терапевтов (с международным участием) , который состоится 12-14 октября в МВЦ "Крокус Экспо" (павильон 3, Зал 20, г. Москва). · Президент Российского научного медицинского общества терапевтов,...

IV Съезд онкологов Московской области 7 октября 2022 года Активное развитие онкологической службы позволяет эффективно решать проблемы, возникающие на всех уровнях оказания помощи пациентам с онкозаболеваниями. Одним из успешных примеров такого взаимодействия является IV...

II Всероссийская конференция с международным участием "Воспаление глаза" 12 ноября 2022 года, Москва Воспалительные заболевания глаза - широко распространенная и многогранная проблема, с которой может столкнуться в своей практике любой специалист. Найти оптимальные алгоритмы...


Journals of «GEOTAR-Media»